9 Meters Biopharma: Funding, Investors & Team (Oct 2026)
9 Meters Biopharma is a company that specializes in gastrointestinal treatments for rare conditions and patients in need. Their product pipeline consists of drugs designed to treat short bowel syndrome and celiac disease. The company is managed by a capable team with experience bringing innovative therapies to market, and owns exclusive worldwide rights to their products, supported by over 150 patents.
9 Meters Biopharma has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Mar 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
9 Meters Biopharma Company Profile and Key Stats
Latest funding round on record: Mar 2023.
9 Meters Biopharma Funding Rounds
9 Meters Biopharma Founders and Leadership Team
Contact details for the 9 Meters Biopharma team: 1 of 1 has an email address on file.
Start 14-day free trial →9 Meters Biopharma Funding Compared to Other Biotechnology Startups
9 Meters Biopharma's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like 9 Meters Biopharma in Biotechnology and Raleigh
Companies Similar to 9 Meters Biopharma
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
9 Meters Biopharma Funding FAQs
What does 9 Meters Biopharma do?
9 Meters Biopharma is a company that specializes in gastrointestinal treatments for rare conditions and patients in need. Their product pipeline consists of drugs designed to treat short bowel syndrome and celiac disease. The company is managed by a capable team with experience bringing innovative therapies to market, and owns exclusive worldwide rights to their products, supported by over 150 patents.
How much funding has 9 Meters Biopharma raised?
9 Meters Biopharma has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Mar 2023.
When did 9 Meters Biopharma last raise funding?
9 Meters Biopharma's most recent funding round on record is an undisclosed round of $5.0M, announced in Mar 2023.
Who founded 9 Meters Biopharma?
FundedIQ lists Jay Madan (Founder) at 9 Meters Biopharma.
Where is 9 Meters Biopharma headquartered?
9 Meters Biopharma is based in Raleigh, North Carolina, United States.
How many employees does 9 Meters Biopharma have?
9 Meters Biopharma is in the 11-50 employee band.
How does 9 Meters Biopharma's funding compare to other Biotechnology startups?
9 Meters Biopharma's latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's 9 Meters Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 9 Meters Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.